Andrzej Lebioda1, Roman Makarewicz1, Bogdan Małkowski2, Maciej Dancewicz3, Janusz Kowalewski3, Wieslawa Windorbska4. 1. Clinic of Oncology and Brachytherapy, Collegium Medicum of Bydgoszcz, Nicolaus Copernicus University in Torun, Poland. 2. Department of Nuclear Medicine, Center of Oncology in Bydgoszcz, Poland ; Department of Positron Emission Tomography and Molecular Imagining, Collegium Medicum of Bydgoszcz, Nicolaus Copernicus University in Torun, Poland. 3. Department of Thoracic Surgery and Tumors, Collegium Medicum of Bydgoszcz, Nicolaus Copernicus University in Torun, Poland ; Department of Thoracic Surgery and Tumors, Center of Oncology in Bydgoszcz, Poland. 4. Department of Radiotherapy, Center of Oncology in Bydgoszcz, Poland.
Abstract
AIM: The study aimed to determine a prognostic value of primary tumor volume measured on the basis of integrated positron emission tomography-computerized tomography (PET-CT) in terms of mediastinal nodal metastases (N2) prediction in non-small-cell lung cancer (NSCLC) patients with PET-CT N2 negative lymph nodes. METHODS: The records of 70 potentially operable NSCLC patients treated with surgical resection were analyzed. All patients underwent diagnostic, preoperative PET-CT, which was the basis for tumor volume calculations as well as the evaluation of N2 nodes status. The logistic regression analysis was employed to determine correlation between mediastinal nodal involvement and volume of primary tumor (izoSUV2.5 volume), that is the volume of primary tumor inside SUV 2.5 line, tumor histology, location (peripheral vs. central), hilar node status. RESULTS: A statistically significant correlation between mediastinal node involvement and izoSUV2.5 volume, tumor histology, locations peripheral vs. central and hilar node status was found. The risk of mediastinal lymph node metastasis is 24% for tumor volume of 100 cm(3) and increases up to 40% for tumor volume of 360 cm(3). An increase of tumor volume by 1 cm(3) increases the risk of lymph node disease by 0.3%. Tumor histology adenocarcinoma vs. squamous cell carcinoma increases the risk of mediastinal lymph node involvement by 195%, location central vs. peripheral by 68% and hilar node involvement by 166%. CONCLUSIONS: The study demonstrates that izoSUV2.5 volume of primary tumor may be considered as a prognostic factor in NSCLC patients, since it strongly correlates with mediastinal lymph node pathological status. This correlation is modified by primary tumor location, histology and hilar node involvement.
AIM: The study aimed to determine a prognostic value of primary tumor volume measured on the basis of integrated positron emission tomography-computerized tomography (PET-CT) in terms of mediastinal nodal metastases (N2) prediction in non-small-cell lung cancer (NSCLC) patients with PET-CT N2 negative lymph nodes. METHODS: The records of 70 potentially operable NSCLCpatients treated with surgical resection were analyzed. All patients underwent diagnostic, preoperative PET-CT, which was the basis for tumor volume calculations as well as the evaluation of N2 nodes status. The logistic regression analysis was employed to determine correlation between mediastinal nodal involvement and volume of primary tumor (izoSUV2.5 volume), that is the volume of primary tumor inside SUV 2.5 line, tumor histology, location (peripheral vs. central), hilar node status. RESULTS: A statistically significant correlation between mediastinal node involvement and izoSUV2.5 volume, tumor histology, locations peripheral vs. central and hilar node status was found. The risk of mediastinal lymph node metastasis is 24% for tumor volume of 100 cm(3) and increases up to 40% for tumor volume of 360 cm(3). An increase of tumor volume by 1 cm(3) increases the risk of lymph node disease by 0.3%. Tumor histology adenocarcinoma vs. squamous cell carcinoma increases the risk of mediastinal lymph node involvement by 195%, location central vs. peripheral by 68% and hilar node involvement by 166%. CONCLUSIONS: The study demonstrates that izoSUV2.5 volume of primary tumor may be considered as a prognostic factor in NSCLCpatients, since it strongly correlates with mediastinal lymph node pathological status. This correlation is modified by primary tumor location, histology and hilar node involvement.
Authors: Abel Gómez-Caro; Samuel Garcia; Noemí Reguart; Pedro Arguis; Marcelo Sanchez; Josep M Gimferrer; Ramon Marrades; Francisco Lomeña Journal: Eur J Cardiothorac Surg Date: 2010-01-29 Impact factor: 4.191
Authors: Paul C Lee; Jeffrey L Port; Robert J Korst; Yaakov Liss; Danish N Meherally; Nasser K Altorki Journal: Ann Thorac Surg Date: 2007-07 Impact factor: 4.330
Authors: Brendon M Stiles; Elliot L Servais; Paul C Lee; Jeffrey L Port; Subroto Paul; Nasser K Altorki Journal: J Thorac Cardiovasc Surg Date: 2009-01 Impact factor: 5.209